[Experiences with single high dosage iphosphamide therapy in metastasizing malignant neoplasms].
D000328:Adult; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005021:Ethylamines / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D010078:Oxazines / Q000009:adverse effects / Q000627:therapeutic use*; D010757:Phosphorous Acids / Q000627:therapeutic use*; D017976:Phosphorus Acids / Q000009:adverse effects
D000477:Alkylating Agents; D005021:Ethylamines; D010078:Oxazines; D010757:Phosphorous Acids; D017976:Phosphorus Acids
Erfahrungen mit Iphosphamid in hoher Einzeldosis bei metastasierten soliden Tumoren.